drugset / Trial / NCT02279342

the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia

NCT02279342

Phase 4 Terminated 1 enrolled Yokohama City University Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the effects of febuxostat on coronary plaque volume in patients with chronic stable angina and hyperuricemia.

Timeline

Start
2014-10
Primary completion
2017-03-31
Completion
2017-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Febuxostat Small molecule 40 mg